<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
<channel>
<title><![CDATA[RSS for Marijn Dekkers]]></title>
<description><![CDATA[Watch breaking news videos and read news updates about Marijn Dekkers on FOXBusiness.com.]]></description>
<link><![CDATA[http://www.foxbusiness.com/search-results/]]></link>
<atom:link xmlns:atom="http://www.w3.org/2005/Atom" type="application/rss+xml" rel="self" href="http://www.foxbusiness.com/search-results/urss?pageid=934733"/>
<item>
<title><![CDATA[Bayer's plastics chief sees room to raise prices]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/05/10/bayer-plastics-chief-sees-room-to-raise-prices/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/05/10/bayer-plastics-chief-sees-room-to-raise-prices/</guid>
<pubDate><![CDATA[Fri, 10 May 2013 11:24:10 EDT]]></pubDate>
<description><![CDATA[Bayer suggested there was room to lift prices at its high-tech plastics and chemicals business this year to counter soaring raw material costs that squeezed first quarter margins.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Bayer Shells Out $1.1B to Buy Conceptus]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/29/bayer-to-acquire-conceptus-to-bolster-contraceptive-business/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/29/bayer-to-acquire-conceptus-to-bolster-contraceptive-business/</guid>
<pubDate><![CDATA[Mon, 29 Apr 2013 09:00:45 EDT]]></pubDate>
<description><![CDATA[The German company plans to acquire Conceptus for $1.1 billion in cash.]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/fb2/Eastman-Kodak-Headquarters.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Bayer Agrees to Buy Conceptus for $1.1 Billion in Cash]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/29/bayer-agrees-to-buy-conceptus-for-11-billion-in-cash/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/29/bayer-agrees-to-buy-conceptus-for-11-billion-in-cash/</guid>
<pubDate><![CDATA[Mon, 29 Apr 2013 07:25:04 EDT]]></pubDate>
<description><![CDATA[Bayer AG (BAYRY, BAYN.XE) has agreed to buy Conceptus Inc. (CPTS) for about $1.1 billion (852 million euros) as the health-care firm aims to broaden its women's contraceptive offerings.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Bayer To Buy Conceptus For $1.1 Billion]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2013/04/29/bayer-to-buy-conceptus-for-11-billion/?]]></link>
<guid>http://www.foxbusiness.com/markets/2013/04/29/bayer-to-buy-conceptus-for-11-billion/</guid>
<pubDate><![CDATA[Mon, 29 Apr 2013 05:06:00 EDT]]></pubDate>
<description><![CDATA[Bayer AG on Monday said it will buy Conceptus, Inc. , whose flagship product is a surgery-free permanent birth control method, for $1.1 billion.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Bayer to buy birth-control devices maker for $1.1 billion]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/29/bayer-to-buy-birth-control-devices-maker-for-11-billion/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/29/bayer-to-buy-birth-control-devices-maker-for-11-billion/</guid>
<pubDate><![CDATA[Mon, 29 Apr 2013 04:27:21 EDT]]></pubDate>
<description><![CDATA[Germany's Bayer AG has agreed to buy U.S. contraceptive devices maker Conceptus for $1.]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/fb2/feeds/Reuters/2013/04/29/2013-04-29T082721Z_2_CBRE93S0JBL00_3_BAYER.JPG</media:thumbnail>
</item>
<item>
<title><![CDATA[Bayer Earnings Rise; Confirms Outlook]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/25/bayer-earnings-rise-confirms-outlook/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/25/bayer-earnings-rise-confirms-outlook/</guid>
<pubDate><![CDATA[Thu, 25 Apr 2013 05:05:02 EDT]]></pubDate>
<description><![CDATA[Bayer AG (BAYN.XE) Thursday confirmed its outlook for the year as it reported a rise in first-quarter earnings, supported by growth at the HealthCare and CropScience units.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Bayer Earnings, Sales Rise on HealthCare, CropScience; Confirms Outlook]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/04/25/bayer-earnings-sales-rise-on-healthcare-cropscience-confirms-outlook/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/04/25/bayer-earnings-sales-rise-on-healthcare-cropscience-confirms-outlook/</guid>
<pubDate><![CDATA[Thu, 25 Apr 2013 02:26:02 EDT]]></pubDate>
<description><![CDATA[Bayer AG (BAYN.XE) Thursday confirmed its outlook for the year as it reported a rise in first-quarter earnings, supported by growth at the HealthCare and CropScience units.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Bayer to Raise 2012 Dividend 15% to EUR1.90]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/02/26/bayer-to-raise-2012-dividend-15-to-eur10/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/02/26/bayer-to-raise-2012-dividend-15-to-eur10/</guid>
<pubDate><![CDATA[Tue, 26 Feb 2013 07:47:04 EST]]></pubDate>
<description><![CDATA[German pharmaceutical and chemical company Bayer AG (BAYN.XE) said Tuesday it plans to increase its dividend for 2012 to 1.90 euros ($2.51) a share from EUR1.65 in 2011.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Bayer's Reinhardt to Leave Co With Aim of Joining Novartis]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2013/01/23/bayer-reinhardt-to-leave-co-with-aim-joining-novartis/?]]></link>
<guid>http://www.foxbusiness.com/news/2013/01/23/bayer-reinhardt-to-leave-co-with-aim-joining-novartis/</guid>
<pubDate><![CDATA[Wed, 23 Jan 2013 02:04:17 EST]]></pubDate>
<description><![CDATA[German chemical and pharmaceutical company Bayer AG (BAYN.XE) said Wednesday Joerg Reinhardt, chief of Bayer HealthCare, won't renew his contract with the company and will instead stand for election as new Director at Swiss health group Novartis AG (NVS).]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Bayer Buys Schiff Nutrition for $1.2B]]></title>
<link><![CDATA[http://www.foxbusiness.com/industries/2012/10/30/bayer-buys-airborne-maker-schiff-nutrition-for-12b/?]]></link>
<guid>http://www.foxbusiness.com/industries/2012/10/30/bayer-buys-airborne-maker-schiff-nutrition-for-12b/</guid>
<pubDate><![CDATA[Tue, 30 Oct 2012 09:18:26 EDT]]></pubDate>
<description><![CDATA[Bayer inked a deal to buy Schiff Nutrition International for $1.2 billion.]]></description>
<media:thumbnail>http://global.fncstatic.com/static/managed/img/fb2/video/854081161001_1934564152001_041712-Varney-Brief.jpg</media:thumbnail>
</item>
<item>
<title><![CDATA[Bayer CEO: Organic Growth Is Priority, Takeovers Not Ruled Out]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/04/26/bayer-ceo-organic-growth-is-priority-takeovers-not-ruled-out/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/04/26/bayer-ceo-organic-growth-is-priority-takeovers-not-ruled-out/</guid>
<pubDate><![CDATA[Thu, 26 Apr 2012 10:42:58 EDT]]></pubDate>
<description><![CDATA[Bayer AG (BAYN.XE) Chief Executive Marijn Dekkers said Thursday organic growth is his priority but didn't rule out acquisitions in the coming years.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Bayer's Confidence Grows As Sales, Profit Rise]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/04/26/bayer-confidence-grows-as-sales-profit-rise/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/04/26/bayer-confidence-grows-as-sales-profit-rise/</guid>
<pubDate><![CDATA[Thu, 26 Apr 2012 02:19:54 EDT]]></pubDate>
<description><![CDATA[German pharmaceutical and chemical company Bayer AG (BAYN.XE) said Thursday it "is increasingly confident for the rest of the year" after a good first quarter with forecast-breaking sales and net profit.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Bayer CEO Dekkers: Organic Growth Most Important Target]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/03/22/bayer-ceo-dekkers-organic-growth-most-important-target/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/03/22/bayer-ceo-dekkers-organic-growth-most-important-target/</guid>
<pubDate><![CDATA[Thu, 22 Mar 2012 05:15:38 EDT]]></pubDate>
<description><![CDATA[Bayer AG (BAYN.XE) views organic growth as the chemical and pharmaceutical company's most important target, Chief Executive Marijn Dekkers told journalists late Wednesday in Duesseldorf.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Bayer Sticks To Target Of Doubling Sales In China By 2015-Report]]></title>
<link><![CDATA[http://www.foxbusiness.com/news/2012/03/11/bayer-sticks-to-target-doubling-sales-in-china-by-2015-report/?]]></link>
<guid>http://www.foxbusiness.com/news/2012/03/11/bayer-sticks-to-target-doubling-sales-in-china-by-2015-report/</guid>
<pubDate><![CDATA[Sun, 11 Mar 2012 07:09:24 EDT]]></pubDate>
<description><![CDATA[FRANKFURT -(Dow Jones)- German pharmaceutical company Bayer AG (BAYN.XE) is sticking to its target of doubling turnover in China by 2015, Chief Executive Marijn Dekkers tells the Frankfurter Rundschau.]]></description>
<media:thumbnail/>
</item>
<item>
<title><![CDATA[Bayer Swings To 4th-period Net; Sales Up 2%]]></title>
<link><![CDATA[http://www.foxbusiness.com/markets/2012/02/28/bayer-swings-to-4th-period-net-sales-up-2/?]]></link>
<guid>http://www.foxbusiness.com/markets/2012/02/28/bayer-swings-to-4th-period-net-sales-up-2/</guid>
<pubDate><![CDATA[Tue, 28 Feb 2012 01:59:00 EST]]></pubDate>
<description><![CDATA[Bayer AG, the Leverkusen, Germany, health-care group, swung to a fourth-quarter profit from a year-earlier loss on 2% higher sales.]]></description>
<media:thumbnail/>
</item>
</channel>
</rss>
